Correlation Between Madrigal Pharmaceuticals and Mesoblast

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Madrigal Pharmaceuticals and Mesoblast at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Madrigal Pharmaceuticals and Mesoblast into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Madrigal Pharmaceuticals and Mesoblast, you can compare the effects of market volatilities on Madrigal Pharmaceuticals and Mesoblast and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Madrigal Pharmaceuticals with a short position of Mesoblast. Check out your portfolio center. Please also check ongoing floating volatility patterns of Madrigal Pharmaceuticals and Mesoblast.

Diversification Opportunities for Madrigal Pharmaceuticals and Mesoblast

0.23
  Correlation Coefficient

Modest diversification

The 3 months correlation between Madrigal and Mesoblast is 0.23. Overlapping area represents the amount of risk that can be diversified away by holding Madrigal Pharmaceuticals and Mesoblast in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mesoblast and Madrigal Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Madrigal Pharmaceuticals are associated (or correlated) with Mesoblast. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mesoblast has no effect on the direction of Madrigal Pharmaceuticals i.e., Madrigal Pharmaceuticals and Mesoblast go up and down completely randomly.

Pair Corralation between Madrigal Pharmaceuticals and Mesoblast

Given the investment horizon of 90 days Madrigal Pharmaceuticals is expected to generate 1.66 times less return on investment than Mesoblast. But when comparing it to its historical volatility, Madrigal Pharmaceuticals is 1.5 times less risky than Mesoblast. It trades about 0.17 of its potential returns per unit of risk. Mesoblast is currently generating about 0.19 of returns per unit of risk over similar time horizon. If you would invest  911.00  in Mesoblast on October 26, 2024 and sell it today you would earn a total of  891.00  from holding Mesoblast or generate 97.8% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy96.61%
ValuesDaily Returns

Madrigal Pharmaceuticals  vs.  Mesoblast

 Performance 
       Timeline  
Madrigal Pharmaceuticals 

Risk-Adjusted Performance

13 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Madrigal Pharmaceuticals are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. Despite quite uncertain technical and fundamental indicators, Madrigal Pharmaceuticals disclosed solid returns over the last few months and may actually be approaching a breakup point.
Mesoblast 

Risk-Adjusted Performance

14 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Mesoblast are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. In spite of very inconsistent basic indicators, Mesoblast displayed solid returns over the last few months and may actually be approaching a breakup point.

Madrigal Pharmaceuticals and Mesoblast Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Madrigal Pharmaceuticals and Mesoblast

The main advantage of trading using opposite Madrigal Pharmaceuticals and Mesoblast positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Madrigal Pharmaceuticals position performs unexpectedly, Mesoblast can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mesoblast will offset losses from the drop in Mesoblast's long position.
The idea behind Madrigal Pharmaceuticals and Mesoblast pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.

Other Complementary Tools

Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios